Literature DB >> 32934029

Correction: Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial.

Bixia Tang, Zhihong Chi, Yingbo Chen, Xiufeng Liu, Di Wu, Jing Chen, Xin Song, Weifeng Wang, Lihou Dong, Haifeng Song, Hai Wu, Hui Feng, Sheng Yao, Shuikui Qin, Xiaoshi Zhang, Jun Guo.   

Abstract

Entities:  

Year:  2020        PMID： 32934029     DOI： 10.1158/1078-0432.CCR-20-3168

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  2 in total

1.  Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review.

Authors:  Qingyue Zheng; Jiarui Li; Hanlin Zhang; Yuanzhuo Wang; Shu Zhang
Journal:  Front Oncol       Date:  2020-12-03       Impact factor: 6.244

Review 2.  Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.

Authors:  Seungyeon Jung; Douglas B Johnson
Journal:  Oncologist       Date:  2022-08-05       Impact factor: 5.837
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.